CEREP Share Price Euronext Paris
Equities
FR0004042232
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- EUR | - |
2023 | Eurofins-Cerep SA Reports Earnings Results for the Full Year Ended December 31, 2022 | CI |
2022 | Eurofins-Cerep SA Reports Earnings Results for the Half Year Ended June 30, 2022 | CI |
Sales 2021 | 41.63M 44.6M 3.72B | Sales 2022 | 47.65M 51.04M 4.26B | Capitalization | 112M 120M 10.02B |
---|---|---|---|---|---|
Net income 2021 | 9M 9.64M 805M | Net income 2022 | 11M 11.78M 984M | EV / Sales 2021 | 2.05 x |
Net cash position 2021 | 1.28M 1.37M 115M | Net cash position 2022 | 12.81M 13.72M 1.15B | EV / Sales 2022 | 2.08 x |
P/E ratio 2021 * |
-
| P/E ratio 2022 |
-
| Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 4.22% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 19/18/19 | |
Damien Séroux
CHM | Chairman | - | 13/14/13 |
Members of the board | Title | Age | Since |
---|---|---|---|
Damien Séroux
CHM | Chairman | - | 13/14/13 |
Director/Board Member | 68 | 10/15/10 | |
Chief Executive Officer | - | 19/18/19 |
1st Jan change | Capi. | |
---|---|---|
+1.77% | 42.75B | |
+47.70% | 41.61B | |
+12.24% | 41.34B | |
-8.83% | 26.59B | |
+7.44% | 25.49B | |
-23.01% | 18.12B | |
+30.56% | 12.24B | |
-1.82% | 11.76B | |
+8.35% | 11B |